Revolution Medicines, Inc.
RVMD- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001628171
In the last 90 days, Revolution Medicines, Inc. insiders filed 0 open-market purchases and 17 sales; 693 institutions reported holding it in 13F filings for Q2 2026, worth $40.1B in total; Duquesne Family Office is the only superinvestor holding it.
Other share classesRVMDW
13F holders, Q1 2023
Institutional positions in Revolution Medicines, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 152
- +17 vs. Q4 2022
- Shares held
- 108.2M
- +20.0M (+22.7%) vs. Q4 2022
- Total value
- $2.34B
- +$242.0M (+11.5%) vs. Q4 2022
- New holders
- 32
- 77 more added
- Sold out
- 15
- 31 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting RVMD on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 693 | $40.1B |
| Q1 2026 | 514 | $19.1B |
| Q4 2025 | 387 | $15.9B |
| Q3 2025 | 323 | $8.96B |
| Q2 2025 | 308 | $7.02B |
| Q1 2025 | 284 | $6.83B |
| Q4 2024 | 281 | $8.45B |
| Q3 2024 | 255 | $7.74B |
| Q2 2024 | 223 | $6.54B |
| Q1 2024 | 210 | $5.18B |
| Q4 2023 | 184 | $4.59B |
| Q3 2023 | 168 | $3.11B |
| Q2 2023 | 139 | $2.99B |
| Q1 2023 | 152 | $2.34B |
| Q4 2022 | 135 | $2.10B |
| Q3 2022 | 142 | $1.74B |
| Q2 2022 | 135 | $1.49B |
| Q1 2022 | 126 | $1.89B |
| Q4 2021 | 117 | $1.85B |
| Q3 2021 | 114 | $1.99B |
| Q2 2021 | 130 | $2.23B |
| Q1 2021 | 128 | $3.05B |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Revolution Medicines, Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Two Sigma Advisers, LP | 175,700 | $3.81M | 0.01% | −3,900−2.2% | Reduced |
| Sofinnova Investments, Inc. | 183,838 | $3.98M | 0.27% | +183,838 | New |
| D. E. Shaw & Co., Inc. | 196,833 | $4.26M | 0.01% | +134,759+217.1% | Added |
| Driehaus Capital Management LLC | 210,768 | $4.57M | 0.06% | −5,539−2.6% | Reduced |
| Nuveen Asset Management, LLC | 238,821 | $5.17M | 0.00% | +37,669+18.7% | Added |
| MPM Oncology Impact Management LP | 247,022 | $5.35M | 1.39% | +97,979+65.7% | Added |
| Citigroup Inc | 263,768 | $5.71M | 0.01% | +156,876+146.8% | Added |
| Polar Asset Management Partners Inc. | 280,000 | $6.06M | 0.11% | +109,100+63.8% | Added |
| Bank of New York Mellon Corp | 292,611 | $6.34M | 0.00% | +33,343+12.9% | Added |
| Susquehanna International Group, LLP | 306,823 | $6.65M | 0.01% | +250,484+444.6% | Added |
| Harvard Management Co Inc | 315,550 | $6.83M | 0.72% | −354,832−52.9% | Reduced |
| Rafferty Asset Management, LLC | 327,586 | $7.10M | 0.05% | +90,268+38.0% | Added |
| Mass General Brigham, Inc | 338,191 | $7.33M | 5.71% | +316,767+1,478.6% | Added |
| Integral Health Asset Management, LLC | 345,000 | $7.47M | 1.55% | +345,000 | New |
| Janus Henderson Group PLC | 352,828 | $7.64M | 0.01% | +343,212+3,569.2% | Added |
| Alliancebernstein L.P. | 376,450 | $8.15M | 0.00% | +160,050+74.0% | Added |
| Morgan Stanley | 384,737 | $8.33M | 0.00% | +46,761+13.8% | Added |
| Bessemer Group Inc | 442,442 | $9.58M | 0.02% | −30,561−6.5% | Reduced |
| Norges Bank | 514,016 | $11.1M | 0.00% | −108,625−17.4% | Reduced |
| Millennium Management LLC | 553,051 | $12.0M | 0.01% | +435,447+370.3% | Added |
| Candriam Luxembourg S.C.A. | 606,332 | $12.1M | 0.08% | −126,173−17.2% | Reduced |
| DAFNA Capital Management LLC | 575,785 | $12.5M | 3.74% | +98,000+20.5% | Added |
| FMR LLC | 598,671 | $13.0M | 0.00% | +168,904+39.3% | Added |
| Charles Schwab Investment Management Inc | 657,227 | $14.2M | 0.00% | +94,140+16.7% | Added |
| Rock Springs Capital Management LP | 702,712 | $15.2M | 0.36% | +702,712 | New |
| Northern Trust Corp | 785,557 | $17.0M | 0.00% | +109,885+16.3% | Added |
| Deerfield Management Company, L.P. (Series C) | 829,737 | $18.0M | 0.40% | −61,850−6.9% | Reduced |
| Frazier Life Sciences Management, L.P. | 854,484 | $18.5M | 1.34% | +854,484 | New |
| Bank of America Corp | 941,733 | $20.4M | 0.00% | +500,318+113.3% | Added |
| Ameriprise Financial Inc | 1,123,958 | $24.3M | 0.01% | +423,035+60.4% | Added |
| Goldman Sachs Group Inc | 1,136,058 | $24.6M | 0.01% | +134,841+13.5% | Added |
| Avidity Partners Management LP | 1,344,800 | $29.1M | 0.97% | −1,130,200−45.7% | Reduced |
| Dimensional Fund Advisors LP | 1,609,987 | $34.9M | 0.01% | +460,094+40.0% | Added |
| Geode Capital Management, LLC | 1,734,077 | $37.6M | 0.00% | +287,221+19.9% | Added |
| Casdin Capital, LLC | 1,810,000 | $39.2M | 3.24% | −715,000−28.3% | Reduced |
| Artal Group S.A. | 2,070,988 | $44.9M | 2.67% | +1,070,988+107.1% | Added |
| Holocene Advisors, LP | 2,104,818 | $45.6M | 0.23% | +2,104,818 | New |
| Baker Bros. Advisors LP | 2,691,493 | $58.3M | 0.32% | +2,469,271+1,111.2% | Added |
| JPMorgan Chase & Co | 3,262,638 | $70.7M | 0.01% | +666,584+25.7% | Added |
| Farallon Capital Management, L.L.C. | 3,283,600 | $71.1M | 0.43% | +1,585,585+93.4% | Added |
| Woodline Partners LP | 3,422,972 | $74.1M | 1.05% | +2,972,957+660.6% | Added |
| The Column Group LLC | 4,577,840 | $99.2M | 35.85% | 00.0% | Unchanged |
| Boxer Capital, LLC | 4,684,264 | $101.5M | 4.98% | +700,000+17.6% | Added |
| Bellevue Group AG | 4,747,900 | $102.8M | 1.49% | −107,262−2.2% | Reduced |
| State Street Corp | 4,811,431 | $104.2M | 0.01% | +1,030,420+27.3% | Added |
| Nextech Invest AG | 4,839,529 | $104.8M | 43.76% | +650,000+15.5% | Added |
| BVF Inc | 4,955,588 | $107.3M | 3.92% | +1,700,000+52.2% | Added |
| Price T Rowe Associates Inc | 5,035,179 | $109.1M | 0.02% | +1,355,137+36.8% | Added |
| EcoR1 Capital, LLC | 5,352,183 | $115.9M | 3.74% | +893,452+20.0% | Added |
| BlackRock Inc. | 7,465,774 | $161.7M | 0.00% | +889,828+13.5% | Added |
| Vanguard Group Inc | 9,302,553 | $201.5M | 0.01% | +1,740,643+23.0% | Added |
| Wellington Management Group LLP | 10,425,368 | $225.8M | 0.04% | +1,551,394+17.5% | Added |
| Cormorant Asset Management, LP | 0 | $0 | 0.00% | −1,895,066−100.0% | Sold out |
| TRV GP III, LLC | 0 | $0 | 0.00% | −1,604,130−100.0% | Sold out |
| TRV GP IV, LLC | 0 | $0 | 0.00% | −1,419,900−100.0% | Sold out |
| Redmile Group, LLC | 0 | $0 | 0.00% | −625,000−100.0% | Sold out |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −383,339−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −98,186−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −27,456−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −22,546−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −19,271−100.0% | Sold out |
| Quantamental Technologies LLC | 0 | $0 | 0.00% | −9,392−100.0% | Sold out |
| Ergoteles LLC | 0 | $0 | 0.00% | −9,100−100.0% | Sold out |
| High Net Worth Advisory Group LLC | 0 | $0 | 0.00% | −2,000−100.0% | Sold out |
| Goodman Advisory Group, LLC | 0 | $0 | 0.00% | −1,763−100.0% | Sold out |
| Belpointe Asset Management LLC | 0 | $0 | 0.00% | −1,078−100.0% | Sold out |
| Investors Research Corp | 0 | $0 | 0.00% | −35−100.0% | Sold out |